Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.

Yuan N, Meng M, Liu C, Feng L, Hou L, Ning Q, Xin G, Pei L, Gu S, Li X, Zhao X.

Mol Clin Oncol. 2014 Mar;2(2):245-251. Epub 2013 Dec 20.

2.

Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.

Zhang M, Zhang X, Zhao S, Wang Y, Di W, Zhao G, Yang M, Zhang Q.

Target Oncol. 2014 Dec;9(4):349-57.

PMID:
24233638
3.

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.

Qiu J, Xue X, Hu C, Xu H, Kou D, Li R, Li M.

J Cancer. 2016 Jan 1;7(2):167-73. doi: 10.7150/jca.10944. eCollection 2016.

4.
5.

Triple negative breast carcinoma is a prognostic factor in Taiwanese women.

Lin C, Chien SY, Chen LS, Kuo SJ, Chang TW, Chen DR.

BMC Cancer. 2009 Jun 18;9:192. doi: 10.1186/1471-2407-9-192.

6.

The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.

Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D.

Onco Targets Ther. 2016 Sep 19;9:5751-5759. eCollection 2016.

7.

[Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].

Ma JG, Wang NJ, Yu WJ.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Oct;31(10):1729-32. Chinese.

8.

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X, Laé M, Pierga JY, Reyal F.

PLoS One. 2015 Dec 18;10(12):e0144359. doi: 10.1371/journal.pone.0144359. eCollection 2015. Erratum in: PLoS One. 2016;11(7):e0159123.

9.

[Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].

Wu SY, Tan Y, Guan YS.

Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):422-8. doi: 10.3760/cma.j.issn.1007-3418.2016.06.006. Chinese.

PMID:
27465945
10.

Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.

Zhang L, Hao C, Dong G, Tong Z.

Breast Care (Basel). 2012 Feb;7(1):13-17. Epub 2012 Feb 13.

11.

Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China.

Ma FJ, Liu ZB, Qu L, Hao S, Liu GY, Wu J, Shao ZM.

Onco Targets Ther. 2014 Nov 27;7:2147-54. doi: 10.2147/OTT.S71095. eCollection 2014.

12.

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.

Yue Y, Astvatsaturyan K, Cui X, Zhang X, Fraass B, Bose S.

PLoS One. 2016 Mar 1;11(3):e0149661. doi: 10.1371/journal.pone.0149661. eCollection 2016.

13.

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.

Eralp Y, Kılıç L, Alço G, Başaran G, Doğan M, Dinçol D, Demirci S, İçli F, Onur H, Saip P, Haydaroğlu A.

J Breast Health. 2014 Oct 1;10(4):209-215. doi: 10.5152/tjbh.2014.1904. eCollection 2014 Oct.

14.

Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.

Zhang Y, Dai J, McNamara KM, Bai B, Shi M, Chan MS, Liu M, Sasano H, Wang X, Li X, Liu L, Ma Y, Cao S, Xing Y, Zhao B, Song Y, Wang L.

BMC Cancer. 2015 Oct 15;15:699. doi: 10.1186/s12885-015-1694-y.

15.

Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.

El Zein D, Hughes M, Kumar S, Peng X, Oyasiji T, Jabbour H, Khoury T.

Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26.

PMID:
28529029
16.

Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancer.

Kim JE, Ahn HJ, Ahn JH, Yoon DH, Kim SB, Jung KH, Gong GY, Kim MJ, Son BH, Ahn SH.

J Breast Cancer. 2012 Jun;15(2):197-202. doi: 10.4048/jbc.2012.15.2.197. Epub 2012 Jun 28.

17.

Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F.

BMC Cancer. 2011 Jul 15;11:299. doi: 10.1186/1471-2407-11-299.

18.

Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia.

Alcantara VS, Lim GH, Lim SH, Sultana R, Lee JA.

J Surg Oncol. 2017 Apr;115(5):523-537. doi: 10.1002/jso.24559. Epub 2017 Feb 7.

PMID:
28168712
19.

[Analysis of prognostic factors related to triple-negative breast cancer].

Shen SJ, Sun Q, Zhou YD, Guan JH, Mao F, Lin Y, Peng L, Xu Y, Wang XF, Xia W, Yao R, Han SM.

Zhonghua Wai Ke Za Zhi. 2013 Nov;51(11):1000-4. Chinese.

PMID:
24444685
20.

Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.

Wang CA, Liu Q, Chen Y, Liu S, Xu J, Cui X, Zhang Y, Piao L.

Exp Mol Pathol. 2015 Apr;98(2):254-9. doi: 10.1016/j.yexmp.2014.12.012. Epub 2015 Jan 21.

PMID:
25617527

Supplemental Content

Support Center